Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study

Immunogenicity, Impact on Carriage and Reactogenicity of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine in Kenyan Children Aged 1–4 Years: A Randomized Controlled Trial

(2014) Laura L. Hammitt et al.   PLoS One

The Differential Impact of Coadministered Vaccines, Geographic Region, Vaccine Product and Other Covariates on Pneumococcal Conjugate Vaccine Immunogenicity

(2013) Daniel E. Park et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Determination of Pneumococcal Serotypes in Meningitis Cases in Niger, 2003–2011

(2013) Jean-Marc Collard et al.   PLoS One

Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Malian children

(2013) Alassane Dicko et al.   Human Vaccines & Immunotherapeutics

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial

(2012) Arto A Palmu et al.   LANCET

Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial

(2011) Alassane Dicko et al.   BMC PUBLIC HEALTH

Review on the immunogenicity and safety of PCV-13 in infants and toddlers

(2011) Marta C Nunes et al.   Expert Review of Vaccines

Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children

(2011) Rosanna Lagos et al.   Human vaccines & immunotherapeutics

Immunogenicity of 10-Valent Pneumococcal Nontypeable Haemophilus Influenzae Protein D Conjugate Vaccine When Administered as Catch-up Vaccination to Children 7 Months to 5 Years of Age

(2011) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the universal immunisation of infants in Brazil

(2010) Ana Marli Christovam Sartori et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months

(2010) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project

(2010) Hope L. Johnson et al.   PLOS MEDICINE

Evaluation of Pneumococcal Polysaccharide Immunoassays Using a 22F Adsorption Step with Serum Samples from Infants Vaccinated with Conjugate Vaccines

(2009) J. T. Poolman et al.   Clinical and Vaccine Immunology

Immunogenicity of a 2-Dose Priming and Booster Vaccination With the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine

(2009) Sven Arne Silfverdal et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines

(2009) Jacek Wysocki et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity

(2009) Nancy Bermal et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL